Lataa...
Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer
BACKGROUND: Survival from gastric cancer remains poor, particularly in Western populations. Previous pre-clinical and subgroup analyses of clinical trials have suggested differing benefits from fluoropyrimidine-based chemotherapeutics for diffuse and intestinal gastric cancer. This analysis examines...
Tallennettuna:
| Julkaisussa: | PLoS One |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5602536/ https://ncbi.nlm.nih.gov/pubmed/28922362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0183891 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|